TNFSF11 and osteoporosis: The traditional pharmacologic therapy consists of drugs like teriparatide or bisphosphonate, of which long‐term safety still remains unknown.9, 28, 29 Here, we reported for the first that tectorigenin exerts anti‐osteoporosis effects in vivo and inhibits RANKL‐induced osteoclastogenesis in vitro.